bupropion has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) refers to hepatic pathologies, including simple fatty liver (SFL), nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis, that may progress to hepatocellular carcinoma." | 5.43 | Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet. ( Cho, HJ; Cho, SJ; Chong, S; Chung, SJ; Kang, IM; Kim, DD; Kim, SB; Lee, JI; Yoon, IS, 2016) |
| "Nonalcoholic fatty liver disease (NAFLD) refers to hepatic pathologies, including simple fatty liver (SFL), nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis, that may progress to hepatocellular carcinoma." | 1.43 | Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet. ( Cho, HJ; Cho, SJ; Chong, S; Chung, SJ; Kang, IM; Kim, DD; Kim, SB; Lee, JI; Yoon, IS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaj, HS | 1 |
| Burrows, M | 1 |
| Blavignac, J | 1 |
| Paron, E | 1 |
| Camacho, F | 1 |
| Gould, E | 1 |
| Barakat, M | 1 |
| Cho, SJ | 1 |
| Kim, SB | 1 |
| Cho, HJ | 1 |
| Chong, S | 1 |
| Chung, SJ | 1 |
| Kang, IM | 1 |
| Lee, JI | 1 |
| Yoon, IS | 1 |
| Kim, DD | 1 |
2 other studies available for bupropion and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.
Topics: Adult; Alanine Transaminase; Bupropion; Double-Blind Method; Female; Humans; Liver; Male; Naltrexone | 2021 |
Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.
Topics: Animals; Bupropion; Choline; Choline Deficiency; Cytochrome P-450 CYP2B1; Diet, High-Fat; Disease Mo | 2016 |